These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

174 related items for PubMed ID: 38576288

  • 1. Correlation Between the Clinicopathological Features of Papillary Thyroid Carcinoma Complicated with Hashimoto's Thyroiditis, BRAF V600E Gene Mutation, and RET Gene Rearrangement.
    Xie M, Xu ZX, Dai M, Zhu YY.
    J Coll Physicians Surg Pak; 2024 Apr; 34(4):445-450. PubMed ID: 38576288
    [Abstract] [Full Text] [Related]

  • 2. Combined effect of Hashimoto's thyroiditis and BRAF(V600E) mutation status on aggressiveness in papillary thyroid cancer.
    Kim SJ, Myong JP, Jee HG, Chai YJ, Choi JY, Min HS, Lee KE, Youn YK.
    Head Neck; 2016 Jan; 38(1):95-101. PubMed ID: 25213729
    [Abstract] [Full Text] [Related]

  • 3. High prevalence of RET, RAS, and ERK expression in Hashimoto's thyroiditis and in papillary thyroid carcinoma in the Korean population.
    Kang DY, Kim KH, Kim JM, Kim SH, Kim JY, Baik HW, Kim YS.
    Thyroid; 2007 Nov; 17(11):1031-8. PubMed ID: 17900235
    [Abstract] [Full Text] [Related]

  • 4. A comprehensive prediction model for central lymph node metastasis in papillary thyroid carcinoma with Hashimoto's thyroiditis: BRAF may not be a valuable predictor.
    Chen Y, Zhao S, Zhang Z, Chen Z, Jiang B, An M, Shang M, Wu X, Zhang X, Chen B.
    Front Endocrinol (Lausanne); 2024 Nov; 15():1429382. PubMed ID: 39363900
    [Abstract] [Full Text] [Related]

  • 5.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 6. Potential relationship between Hashimoto's thyroiditis and BRAF(V600E) mutation status in papillary thyroid cancer.
    Zeng RC, Jin LP, Chen ED, Dong SY, Cai YF, Huang GL, Li Q, Jin C, Zhang XH, Wang OC.
    Head Neck; 2016 Apr; 38 Suppl 1():E1019-25. PubMed ID: 26041461
    [Abstract] [Full Text] [Related]

  • 7. Fine-needle aspiration molecular analysis for the diagnosis of papillary thyroid carcinoma through BRAF V600E mutation and RET/PTC rearrangement.
    Pizzolanti G, Russo L, Richiusa P, Bronte V, Nuara RB, Rodolico V, Amato MC, Smeraldi L, Sisto PS, Nucera M, Bommarito A, Citarrella R, Lo Coco R, Cabibi D, Lo Coco A, Frasca F, Gulotta G, Latteri MA, Modica G, Galluzzo A, Giordano C.
    Thyroid; 2007 Nov; 17(11):1109-15. PubMed ID: 17727338
    [Abstract] [Full Text] [Related]

  • 8.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 9. Association between BRAF and RAS mutations, and RET rearrangements and the clinical features of papillary thyroid cancer.
    Ming J, Liu Z, Zeng W, Maimaiti Y, Guo Y, Nie X, Chen C, Zhao X, Shi L, Liu C, Huang T.
    Int J Clin Exp Pathol; 2015 Nov; 8(11):15155-62. PubMed ID: 26823860
    [Abstract] [Full Text] [Related]

  • 10.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 11. Concomitant BRAF(V600E) mutation and RET/PTC rearrangement is a frequent occurrence in papillary thyroid carcinoma.
    Guerra A, Zeppa P, Bifulco M, Vitale M.
    Thyroid; 2014 Feb; 24(2):254-9. PubMed ID: 23806056
    [Abstract] [Full Text] [Related]

  • 12. Integrating BRAFV600E mutation, ultrasonic and clinicopathologic characteristics for predicting the risk of cervical central lymph node metastasis in papillary thyroid carcinoma.
    Zhang Z, Zhang X, Yin Y, Zhao S, Wang K, Shang M, Chen B, Wu X.
    BMC Cancer; 2022 Apr 27; 22(1):461. PubMed ID: 35473554
    [Abstract] [Full Text] [Related]

  • 13.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 14. Does papillary thyroid carcinoma have a better prognosis with or without Hashimoto thyroiditis?
    Kwak HY, Chae BJ, Eom YH, Hong YR, Seo JB, Lee SH, Song BJ, Jung SS, Bae JS.
    Int J Clin Oncol; 2015 Jun 27; 20(3):463-73. PubMed ID: 25312294
    [Abstract] [Full Text] [Related]

  • 15.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 16.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 17.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 18. BRAF mutation positive papillary thyroid carcinoma is less advanced when Hashimoto's thyroiditis lymphocytic infiltration is present.
    Marotta V, Guerra A, Zatelli MC, Uberti ED, Di Stasi V, Faggiano A, Colao A, Vitale M.
    Clin Endocrinol (Oxf); 2013 Nov 27; 79(5):733-8. PubMed ID: 23469895
    [Abstract] [Full Text] [Related]

  • 19. [RET/PTC rearrangement affects multifocal formation of papillary thyroid carcinoma].
    Zhang X, Su X, Chen WC, Li Y, Yang ZY, Deng WZ, Deng TC, Yang AK.
    Zhonghua Er Bi Yan Hou Tou Jing Wai Ke Za Zhi; 2017 Jun 07; 52(6):435-439. PubMed ID: 28635216
    [Abstract] [Full Text] [Related]

  • 20. Association Between BRAFV600E Mutation and the American College of Radiology Thyroid Imaging, Reporting and Data System in Solitary Papillary Thyroid Carcinoma.
    Shangguan R, Hu YP, Huang J, Yang SJ, Ye L, Lin RX, Zhu J, Zhang TL, Ying L, Li P.
    Acad Radiol; 2019 Feb 07; 26(2):154-160. PubMed ID: 29941398
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 9.